Open AccessCOVID-19-induced psychosis: new challenges for early career psychiatrists
Author(s) -
Tanay Maiti,
Lamiaà Essam,
Laura Orsolini,
Rodrigo Ramalho,
Sarah El Halabi,
Vinh-Son Nguyen,
Ahmet Gürcan,
Jitender Jakhar,
Mariana Pinto da Costa,
Margaret Isioma Ojeahere,
Sheikh Shoib,
Ilya Fedotov
Publication year - 2021
Publication title -
rossijskij mediko-biologičeskij vestnik imeni akademika i. p. pavlova/rossijskij mediko-biologičeskij vestnik imeni akademika i.p. pavlova
Language(s) - English
Resource type - Journals
eISSN - 2500-2546
pISSN - 0204-3475
DOI - 10.17816/pavlovj72035
Subject(s) - psychiatry , exacerbation , psychosis , harm , pandemic , covid-19 , psychology , antipsychotic , delirium , schizophrenia (object oriented programming) , medicine , mental health , disease , social psychology , pathology , infectious disease (medical specialty) , immunology
The COVID-19 pandemic and its impact on mental health has remained immense and global in all senses. Various types of induced psychiatric disorders, both new episodes and exacerbation of the preexisiting ones has been reported - starting from adjustment disorder to full psychotic illnesses.
Various clinical symptoms, including systematized delusions, affective symptoms and self harm ideas has been mentioned needing upto prolonged admission and in patient care. Various etiopathogenetic models, incluing direct neural infection to cytokine storms or unmasking of the hidden vulnerabilities has been proposed however this needs further research. Traditional antipsychotic pharmacological agents has been proven to work well though special attention to pharmacological interactions is needed with caution for co morbid conditions and chance of side effects.
We collaborated in worldwide Task Force of early career psychiatrists and prepared the definition of our point of view.